Unixell Biotechnology has dosed its first Parkinson’s disease patient in a clinical study of its stem cell therapy candidate, UX-DA001. According to a press release from Unixell, a surgeon at Ruijin Hospital in Shanghai successfully injected the experimental medication directly into a patient’s brain. UX-DA001 is derived from…
Walk in New York, a new clinic from Wandercraft, will allow people with Parkinson’s disease to access robotic-assisted training intended to help in the rehabilitation of patients’ walking ability. “Our mission has always been to restore everyday mobility, building hand in hand with the community of people…
U.K.-based charity Cure Parkinson’s is marking its 20th anniversary by inviting supporters to take on walking challenges to raise money for Parkinson’s disease research and advocacy. “Our aim is to cure Parkinson’s and the only way we will do this is through the help of all our incredible supporters,” Helen…
Living within three miles of a golf course may increase the risk of developing Parkinson’s disease, possibly due to pesticide exposure, a study reported. The risk decreased with distance, the researchers found. Areas with water systems vulnerable to pesticide pollution from golf courses had a higher prevalence of Parkinson’s,…
The Parkinson’s and Movement Disorder (PMD) Alliance, a U.S.-based nonprofit, is seeking participants willing to take part in an online survey about the experiences of patients and caregivers with off time in Parkinson’s disease. Off time, or periods when medication wears off and symptoms return,…
Angels on Call Homecare has received the 2025 Best of Home Care – Leader in Experience Award for their work providing care to people with Parkinson’s disease and dementia. “This award is a powerful reminder of our commitment to revolutionizing the experience of care,” Eric Dalton, vice president…
A $50,000 grant will allow Stockton University to provide free SPEAK OUT! voice therapy to people in New Jersey with Parkinson’s disease. Parkinson Voice Project (PVP), which is providing the grant, designed the SPEAK OUT! program to help Parkinson’s patients with motor symptoms including low speech volume, slurred…
The Michael J. Fox Foundation (MJFF) has awarded a $14.7 million research grant to Verily, an artificial intelligence platform for health analytics, to generate a detailed set of molecular information for Parkinson’s disease research. Verily will analyze biological samples, including blood and cerebrospinal fluid, from participants in the…
The Michael J. Fox Foundation (MJFF) is expanding its Parkinson’s Progression Markers Initiative (PPMI) to provide free Parkinson’s disease risk screening to people 40 years and older. The move will allow PPMI to screen more people using blood testing and tests of smell loss, a possible early…
Defects in VPS13C, a protein whose dysfunction has been linked to Parkinson’s disease, can prevent cells from repairing damage to their waste disposal systems, a study shows. VPS13C and other proteins associated with genetic forms of Parkinson’s help repair damaged lysosomes, which are cell components that recycle waste. Without…
Get regular updates to your inbox.
